Skip to main content

Horiva vs Clue for Perimenopause: On-Device Privacy vs Ad-Supported

Last updated: March 21, 2026

TLDR

Horiva is purpose-built for perimenopause with on-device data storage. Clue is a polished period tracker with an ad-supported free tier. The fundamental difference: Horiva cannot access your health data by design; Clue's business model depends on processing it.

Feature Horiva Clue Horiva
Monthly cost $9/mo (14-day trial) Free + $14.99/mo $9/mo
Privacy model Data monetization Data monetization On-device only
Perimenopause focus General General Perimenopause-first
Doctor reports No No Yes — PDF export
Horiva vs Clue Feature Comparison
FeatureHorivaClueNotes
Monthly cost$9/moFree / $14.99Horiva 14-day trial available
Perimenopause focusBuilt for perimenopauseGeneral period trackerCore design difference
Data privacy modelOn-device onlyAd-supportedStructural difference, not policy
Doctor reportsYes — PDF exportNoFormatted for medical review
Available in USYesYesBoth available in US

The Core Tension

Clue and Horiva represent two different answers to the same question: how should a health tracking app be funded?

Clue’s answer is advertising and data partnerships. Horiva’s answer is a subscription fee. These are not just business model differences — they determine what the app can and cannot do with your health data structurally.

What Ad-Supported Means in Practice

A free tier requires revenue. When health data is the product, that revenue comes from processing user data for advertising or research purposes. Clue has been more careful than some competitors — the app has not faced FTC enforcement — but the free model still involves health data contributing to the business.

For women tracking sensitive symptoms — mood disruption, sexual health changes, bleeding patterns — the question is whether they are comfortable with that arrangement.

On-Device Architecture

Horiva’s on-device storage is an architectural decision, not a privacy policy. The data is encrypted and stored locally on your device. When you log a symptom, nothing is transmitted to Horiva’s servers. Generating a PDF report happens on your device.

This means Horiva literally cannot share your data — not because of a policy commitment, but because the data does not exist on Horiva’s infrastructure.

Perimenopause Specificity

Clue was designed for regular cycles. The period prediction engine, ovulation tracking, and cycle phase notifications all assume predictable patterns. During perimenopause, those patterns break down. Cycles become longer, then shorter, then skip. Clue’s core features become less useful exactly when the tracking becomes more important.

Horiva’s tracking categories are built around what actually changes in perimenopause: hot flash frequency and intensity, night sweat patterns, cognitive symptoms, mood variability, and cycle irregularity as a data point rather than an anomaly to correct.

Neither option feel right?

Most women pay for features they don't use. Horiva is $9/mo with no data selling — ever.

Verdict

Horiva is the stronger choice for perimenopause-specific tracking with privacy. Clue is the stronger choice for women who want a polished free period tracker and are comfortable with the ad-supported data model. The two apps serve different needs.

PROS & CONS

Horiva

Pros

  • Symptom categories map to perimenopause — hot flashes, brain fog, sleep, irregular cycles
  • On-device encryption prevents any server-side data access
  • PDF export designed for gynecology and endocrinology appointments

Cons

  • Paid-only after 14-day trial
  • No community or peer-support features at launch
  • Newer than Clue — shorter track record

PROS & CONS

Clue

Pros

  • Free tier with no upfront cost
  • Research partnerships with universities add scientific credibility
  • Consistent app quality and design

Cons

  • Ad-supported model processes health data to fund operations
  • Cycle predictions lose accuracy with irregular perimenopause cycles
  • No perimenopause-specific tracking categories in free tier

Q&A

Is Horiva or Clue better for perimenopause?

Horiva is better for perimenopause. Clue was designed for regular cycle and fertility tracking; perimenopause features were added to an existing product. Horiva was designed from the start for the perimenopause transition — irregular cycles, hot flash patterns, brain fog, mood changes, and sleep disruption are all first-class features, not additions.

Q&A

Does Clue's free tier share your health data?

Clue's free tier is ad-supported. Clue processes user data to fund operations, which includes advertising-related data use. Clue's privacy policy permits sharing aggregated health data with research partners. The company has not faced FTC enforcement like Flo has, but the free tier's business model involves health data processing.

Q&A

Why does Horiva cost money when Clue is free?

Clue's free tier is funded by advertising and data processing. Horiva does not have an ad-supported tier because that model requires processing health data. The $9/mo subscription funds the product directly. On-device storage is only economically viable if users pay — there is no advertiser revenue to offset costs.

Can I try Horiva before paying?
Yes. Horiva offers a 14-day trial with no payment information required upfront. You get full access to all features during the trial period.
Is Clue free forever?
Clue's basic free tier has no time limit. The free version includes period tracking and limited symptom logging. Clue Plus at $14.99/month adds detailed analysis, data export, and additional features. Clue has maintained the free tier since its launch.
Does Clue work for irregular cycles?
Clue can log irregular cycles and the app has added some perimenopause content, but the prediction engine is built for regular cycles. As cycle irregularity increases during perimenopause, Clue's predictions become less reliable. The symptom logging features work regardless of cycle regularity.

Related Comparisons